Biochips Market Size, Share, Opportunities, And Trends By Type (DNA, Protein, Lab-on, Others), By Application (Drug Discovery and Development, Disease Diagnostics, Genomics, Proteomics, Agriculture, Others), By End-User (Biotechnology & Pharmaceutical Companies, Hospitals & Diagnostics Centers, Academic & Research Institutes, Others) And By Geography - Forecasts From 2025 To 2030

Biochips Market Size:

The Biochips Market is set to expand from USD 14.590 billion in 2025 to USD 26.292 billion by 2030, with a 12.50% compound annual growth rate (CAGR).

Biochips Market Trends:

A biochip is a set of diminished microarrays that are placed on a strong substrate that allows many experiments to be executed at the same time to obtain output in less time.

It contains millions of sensor elements or biosensors and, unlike microchips, is not an electronic device. A biochip acts like a microreactor that can detect particular analytes like enzymes, proteins, DNA, biological molecules or antibodies. Its main functions are to perform hundreds of biological reactions in a few seconds, tracking humans/animals, restoring records, and as a BP sensor, glucose detector, and oxygen sensor in the medical field. Biochips Market has garnered a substantial share due to the rise in prevalence of life-threatening disorders, a surge in the number of aged people who are susceptible to cancer, an increase in its applications, and a high demand for personalized medicines.

Additionally, the growth in healthcare expenditure across the globe, increased government funding, and R&D investment in biotechnology by the key players are also supporting the growth of the market. However, high prices, lack of knowledge among consumers, and a threat to individual privacy are acting as restraints in the growth of the market.

The Biochips Market is an exhaustive study of this niche technology market which aims to present the key market trends through various chapters focusing on different aspects of the market. The study provides a detailed market overview through the market dynamics sections which detail key markets, drivers, restraints, and opportunities in the current market. The report analyzes key opportunities in regional markets and the current technology penetration through lifecycle analysis. The report also analyzes the market through comprehensive market segmentation by type, application, end-user, and geography.

The biochips market has been segmented based on type, application, end-user, and geography. Based on type the market has been segmented into DNA Chip, Protein Chip, Lab-on-Chip, and others. By application, the market has been classified into Drug Discovery and Development, Disease Diagnostics, Genomics, Proteomics, Agriculture, and Others. By end-user, the market has been classified as Biotechnology & Pharmaceutical Companies, Hospitals & Diagnostics Centers, Academic & Research Institutes, and Others.

Regional analysis has been provided with detailed analysis and forecast for the period. The global market has been broken down into North America, South America, Europe, the Middle East and Africa, and the Asia Pacific regions. The report also analyzes 15 countries across these regions with a thorough analysis and forecast, along with prevailing market trends and opportunities that each of these countries presents for the manufacturers.

Major players in the biochips market have been covered along with their relative competitive positions and strategies. The report also mentions recent deals and investments of different market players over the last year. The company profiles section details the business overview, financial performance for the past three years, key products and services being offered along with the recent developments of these important players in the biochips market.

Segmentation

• By Type
  • DNA Chip
  • Protein Chip
  • Lab-on-Chip
  • Cell-Based & Tissue Chips
• By Application
  • Drug Discovery and Development
  • Disease Diagnostics
  • Genomics
  • Proteomics
  • Agriculture
  • Environmental Testing
  • Others
• By End-User
  • Biotech & Pharma
  • Hospitals & Diagnostics Centers
  • Academic & Research Institutes
  • CROs & Government Labs
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Others
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Others
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Others
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Taiwan
    • Others

1. EXECUTIVE SUMMARY 

2. MARKET SNAPSHOT

2.1. Market Overview

2.2. Market Definition

2.3. Scope of the Study

2.4. Market Segmentation

3. BUSINESS LANDSCAPE 

3.1. Market Drivers

3.2. Market Restraints

3.3. Market Opportunities 

3.4. Porter’s Five Forces Analysis

3.5. Industry Value Chain Analysis

3.6. Policies and Regulations 

3.7. Strategic Recommendations 

4. TECHNOLOGICAL OUTLOOK 

5. BIOCHIPS MARKET BY TYPE

5.1. Introduction

5.2. DNA Chip

5.3. Protein Chip

5.4. Lab-on-Chip

5.5. Cell-Based & Tissue Chips

6. BIOCHIPS MARKET BY APPLICATION 

6.1. Introduction

6.2. Drug Discovery and Development

6.3. Disease Diagnostics

6.4. Genomics

6.5. Proteomics

6.6. Agriculture

6.7. Environmental Testing

6.8. Others

7. BIOCHIPS MARKET BY END-USER

7.1. Introduction

7.2. Biotech & Pharma

7.3. Hospitals & Diagnostics Centers

7.4. Academic & Research Institutes

7.5. CROs & Government Labs

8. BIOCHIPS MARKET BY GEOGRAPHY

8.1. Introduction

8.2. North America

8.2.1. United States

8.2.2. Canada

8.2.3. Mexico

8.3. South America

8.3.1. Brazil 

8.3.2. Argentina

8.3.3. Others

8.4. Europe

8.4.1. United Kingdom

8.4.2. Germany

8.4.3. France

8.4.4. Italy

8.4.5. Others

8.5. Middle East & Africa

8.5.1. Saudi Arabia

8.5.2. UAE

8.5.3. Others

8.6. Asia Pacific

8.6.1. Japan

8.6.2. China

8.6.3. India

8.6.4. South Korea

8.6.5. Taiwan

8.6.6. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

9.1. Major Players and Strategy Analysis

9.2. Market Share Analysis

9.3. Mergers, Acquisitions, Agreements, and Collaborations

9.4. Competitive Dashboard

10. COMPANY PROFILES

10.1. Abbott Laboratories

10.2. Revvity, Inc.

10.3. Standard BioTools Inc.

10.4. Randox Laboratories

10.5. Thermo Fisher Scientific

10.6. Bio Rad Laboratories

10.7. Illumina Inc.

10.8. Agilent Technologies

10.9. GE Healthacre

10.10. Cepheid Inc,

10.11. F. Hoffmann-La Roche AG

11. RESEARCH METHODOLOGY

LIST OF FIGURES

LIST OF TABLES

Abbott Laboratories

Revvity, Inc.

Standard BioTools Inc.

Randox Laboratories

Thermo Fisher Scientific

Bio Rad Laboratories

Illumina Inc.

Agilent Technologies

GE Healthacre

Cepheid Inc,

F. Hoffmann-La Roche AG

Sorry, the research methodology content could not be loaded.